Skip to content

Akari Therapeutics, Plc: 20-F filed 2022-05-16

What Akari Therapeutics, Plc reported in its annual report (foreign private issuer) filed 2022-05-16 (fiscal FY 2021): 33 published measures, 90 facts as tagged in accession 0001410578-22-001546.

This filing

Form
20-F (annual report (foreign private issuer))
Filed
2022-05-16
Fiscal period
fiscal FY 2021
Accession
0001410578-22-001546 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Akari Therapeutics, Plc filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-12-3111,648,028USD
At 2020-12-3114,604,807USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-12-316,093,446USD
At 2020-12-315,220,488USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-12-315,554,582USD
At 2020-12-319,384,319USD
At 2019-12-317,598USD
At 2018-12-314,368,711USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-12-319,361,270USD
At 2020-12-3114,055,777USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-17,424,237USD365
2020-01-01 to 2020-12-31-17,081,617USD366
2019-01-01 to 2019-12-31-16,846,203USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-18,846,528USD365
2020-01-01 to 2020-12-31-16,950,408USD366
2019-01-01 to 2019-12-31-12,918,313USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-12-3114,292,753USD365
2020-01-01 to 2020-12-3125,073,961USD366
2019-01-01 to 2019-12-3112,647,953USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-12-31-199,705,048USD
At 2020-12-31-182,280,811USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-01-01 to 2021-12-314,292,112,667shares365
2020-01-01 to 2020-12-313,159,037,588shares366
2019-01-01 to 2019-12-311,830,998,609shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-01-01 to 2021-12-314,292,112,667shares365
2020-01-01 to 2020-12-313,159,037,588shares366
2019-01-01 to 2019-12-311,830,998,609shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD/shares365
2020-01-01 to 2020-12-31-0.01USD/shares366
2019-01-01 to 2019-12-31-0.01USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD/shares365
2020-01-01 to 2020-12-31-0.01USD/shares366
2019-01-01 to 2019-12-31-0.01USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2020-01-01 to 2020-12-310USD366
2019-01-01 to 2019-12-310USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-12-310USD
At 2020-12-310USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-12-31314,650USD365
2020-01-01 to 2020-12-31325,523USD366
2019-01-01 to 2019-12-311,047,387USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-17,214,136USD365
2020-01-01 to 2020-12-31-17,980,974USD366
2019-01-01 to 2019-12-31-16,963,120USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-12-3111,625,099USD
At 2020-12-3114,577,657USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-12-311,788,563USD
At 2020-12-313,380,782USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-01-01 to 2021-12-3117,214,136USD365
2020-01-01 to 2020-12-3117,980,974USD366
2019-01-01 to 2019-12-3116,963,120USD365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2021-01-01 to 2021-12-318,080,681USD365
2020-01-01 to 2020-12-319,160,770USD366
2019-01-01 to 2019-12-318,223,700USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-01-01 to 2021-12-319,133,455USD365
2020-01-01 to 2020-12-318,820,204USD366
2019-01-01 to 2019-12-318,739,420USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-12-313,847,331,923shares
At 2020-12-313,847,331,923shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2021-12-319,361,270USD
At 2020-12-3114,055,777USD
At 2019-12-315,731,691USD
At 2018-12-315,967,967USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-12-31-540,967USD
At 2020-12-31-648,065USD
At 2019-12-31-348,860USD
At 2018-12-31-352,426USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2021-12-31164,938USD
At 2020-12-31164,938USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-12-31164,938USD
At 2020-12-31164,938USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2021-12-3122,929USD
At 2020-12-3127,150USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-12-313,184,883USD
At 2020-12-311,839,706USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-17,424,237USD365
2020-01-01 to 2020-12-31-17,081,617USD366
2019-01-01 to 2019-12-31-16,846,203USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-17,317,139USD365
2020-01-01 to 2020-12-31-17,380,822USD366
2019-01-01 to 2019-12-31-16,842,637USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-01-01 to 2021-12-314,126USD365
2020-01-01 to 2020-12-318,907USD366
2019-01-01 to 2019-12-3119,205USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-210,101USD365
2020-01-01 to 2020-12-31899,357USD366
2019-01-01 to 2019-12-31116,917USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-01-01 to 2021-12-3114,292,753USD365
2020-01-01 to 2020-12-3125,046,461USD366
2019-01-01 to 2019-12-3112,647,953USD365

Inspect the source

Entity
Akari Therapeutics, Plc / CIK 0001541157
Captured
2026-09-20T09:17:38.520Z
SEC response SHA-256
28aa6200c3956b4742e82320b97671468c61e673338f20b4055d5cab77ff39a0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001541157.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))